Digital Twin Cardio-Pulmonary Bypass Global Market Report 2025

The digital twin cardio-pulmonary bypass market size has grown exponentially in recent years. It will grow from $0.5 billion in 2024 to $0.6 billion in 2025 at a compound annual growth rate (CAGR) of 20.3%. The growth during the historic period can be attributed to the increasing prevalence of coronary artery disease and valvular disorders, the expansion of tertiary cardiothoracic surgery centers, broader health insurance coverage for open-heart procedures, perioperative patient safety and quality reporting requirements, and hospitals’ focus on operating room efficiency and throughput.

The digital twin cardio-pulmonary bypass market size is expected to see rapid growth in the next few years. It will grow to $1.24 billion in 2029 at a compound annual growth rate (CAGR) of 20%. The growth during the forecast period can be attributed to an aging population increasing the number of surgical candidates for complex cases, rising survivorship in congenital heart disease requiring reinterventions, payer demands for cost transparency and outcome accountability, stricter accreditation requirements for cardiothoracic programs, and the expansion of regional referral networks for high-risk surgeries. Key trends in the forecast period include AI and machine learning-calibrated patient digital twins, development of hybrid cardiopulmonary bypass systems, fifth-generation mobile networks for real-time intraoperative data streaming, interoperability between electronic health records and health information exchanges, and augmented reality and virtual reality training modules for perfusion workflows.

The rising prevalence of cardiovascular diseases is expected to drive the growth of the digital twin cardio-pulmonary bypass market in the coming years. Cardiovascular diseases refer to a group of disorders affecting the heart and blood vessels, including coronary artery disease, heart failure, stroke, and hypertension. The increase in cardiovascular diseases is linked to aging populations, as aging weakens the heart and blood vessels, raising the risk of heart-related conditions. Digital twin cardio-pulmonary bypass allows clinicians to simulate a patient’s heart and circulatory system, helping predict surgical outcomes, optimize procedures, and reduce complications, thereby supporting the management and treatment of cardiovascular diseases. For example, in October 2024, according to the Centers for Disease Control and Prevention, in 2023 cardiovascular disease caused 919,032 deaths in the United States, accounting for one in every three deaths. Coronary heart disease remained the most common type of heart disease, and approximately one in six deaths from cardiovascular diseases occurred among adults younger than 65 years. Hence, the rising prevalence of cardiovascular diseases is fueling the growth of the digital twin cardio-pulmonary bypass market.

The growing demand for precision medicine is expected to boost the growth of the digital twin cardio-pulmonary bypass market in the coming years. Precision medicine is a medical approach that customizes treatment and prevention strategies according to an individual’s genetic makeup, environment, and lifestyle. The demand for precision medicine is increasing because advancements in genomics help doctors understand a patient’s genetic profile, enabling more targeted and effective treatments. Digital twin cardio-pulmonary bypass supports precision medicine by creating a detailed, patient-specific virtual model of the cardiovascular system, allowing clinicians to simulate procedures, predict individual responses, and optimize treatment strategies tailored to each patient. For instance, in February 2024, according to the Personalized Medicine Coalition, in 2023 the FDA approved 16 new personalized therapies for patients with rare diseases, a significant increase from six approvals in 2022. Therefore, the growing demand for precision medicine is driving the growth of the digital twin cardio-pulmonary bypass market.

The rising investments in medical research are expected to propel the growth of the digital twin cardio-pulmonary bypass market in the coming years. Medical research involves systematic investigation to understand human health, diseases, and medical conditions and to develop new treatments, drugs, medical devices, and technologies for improved patient care. Investments in medical research are increasing because healthcare systems and patients seek advanced, effective, and personalized medical solutions, which require innovative technologies and treatments. These investments accelerate the development of digital twin cardio-pulmonary bypass technology by funding high-fidelity simulation models that accurately replicate human cardiovascular physiology, enhancing surgical planning, patient safety, and treatment outcomes. For example, in December 2023, according to the Department for Science, Innovation and Technology, the United States allocated 2 billion dollars toward biotechnology and biomanufacturing. Japan aims to achieve the world’s most advanced bioeconomy by 2030. France is investing 870 million dollars to develop and produce biomedicines. Meanwhile, China’s latest Five-Year Plan pledges to accelerate the development and expand the size and strength of its bioeconomy. Hence, the increasing investments in medical research are driving the growth of the digital twin cardio-pulmonary bypass market.

Major players in the digital twin cardio-pulmonary bypass market are Tata Consultancy Services Limited (TCS), Medtronic plc, Siemens Healthineers AG, Koninklijke Philips N.V., GE HealthCare Technologies Inc., Boston Scientific Corporation, Dassault Systèmes SE, Terumo Corporation, Synopsys Inc., Getinge AB, LivaNova PLC, Materialise NV, HeartFlow Inc., CFD Research Corporation (CFDRC), Kitware Inc., Circle Cardiovascular Imaging Inc., Keya Medical Inc., inHEART SAS, PrediSurge Inc., InSilicoTrials Technologies SA.

North America was the largest region in the digital twin cardio-pulmonary bypass market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in digital twin cardio-pulmonary bypasss report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The fast surge in U.S. tariffs and the trade tensions that followed in spring 2025 are heavily affecting the medical equipment sector, particularly for imported imaging machine components, surgical-grade stainless steel, and plastic disposables. Hospitals and clinics resist price hikes, pressuring manufacturers’ margins. Regulatory hurdles compound the problem, as tariff-related supplier changes often require re-certification of devices, delaying time-to-market. Companies are mitigating risks by dual-sourcing critical parts, expanding domestic production of commoditized items, and accelerating R&D in cost-efficient materials.

The digital twin cardio-pulmonary bypass market research report is one of a series of new reports that provides digital twin cardio-pulmonary bypass market statistics, including digital twin cardio-pulmonary bypass industry global market size, regional shares, competitors with the digital twin cardio-pulmonary bypass market share, digital twin cardio-pulmonary bypass market segments, market trends, and opportunities, and any further data you may need to thrive in the digital twin cardio-pulmonary bypass industry. This digital twin cardio-pulmonary bypass market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

A digital twin cardio-pulmonary bypass is a virtual representation of a patient’s cardiovascular and pulmonary systems, designed to simulate physiological responses during bypass procedures. It combines real-time data, computational modeling, and predictive analytics to evaluate hemodynamic changes and optimize procedural strategies. The digital model allows precise monitoring, testing, and decision-making without directly intervening on the actual biological system.

The primary components of digital twin cardio-pulmonary bypass include software, hardware, and services. Software consists of programs and data that direct computer hardware to perform specific tasks, enabling analysis, processing, and decision support. These systems can be deployed on-premises or via cloud platforms and are applied in various areas, including cardiac surgery, pulmonary surgery, research and development, training and education, and other applications. End-users include hospitals, specialty clinics, academic and research institutes, and other healthcare organizations.

The countries covered in the digital twin cardio-pulmonary bypass market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The digital twin cardio-pulmonary bypass market consists of revenues earned by entities by providing services such as real-time monitoring and intraoperative support, training and education for medical professionals, predictive analytics and outcome assessment, software and platform licensing. The market value includes the value of related goods sold by the service provider or included within the service offering. The digital twin cardio-pulmonary bypass market also includes sales of heart-lung machines, advanced patient monitoring systems, virtual and augmented reality surgical planning tools, multi-scale computational heart models, and electrode optimization systems. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.